A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants by Afolabi, M, Ndure, J, Drammeh, A, Darboe, F, Mehedi, SR, Rowland-Jones, S, Borthwick, N, Black, A, Ambler, G, John-Stewart, G, Reilly, M, Hanke, T, Flanagan, K

Negative Correlation between Circulating CD4+FOXP3+CD127− Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria–Tetanus–Pertussis Vaccin... by Ndure, J, Noho-Konteh, F, Adetifa, J, Cox, M, Barker, F, Le, M, Sanyang, L, Drammeh, A, Whittle, H, Clarke, E, Plebanski, M, Rowland-Jones, S, Flanagan, K

PedVacc Infant HIV-1 Vaccine Trials: First Stage Towards a Vaccine Against Breast Milk Transmission of HIV-1 by Hanke, T, Flanagan, K, Jaoko, W, John-Stewart, G, Reilly, M, Payne, B, Afolabi, M, Ambler, G, Black, A, Borthwick, N, Gichuhi, C, Mundia, M, Ndure, J, Njuguna, I, Osanya, J

PedVacc001:Safety and Immunogenicity of a Candidate HIV-1 Vaccine, MVA.HIVA, Administered to Healthy Gambian Infants Born to HIV-1/2-Uninfected Mothers by Afolabi, M, Ndure, J, Mueller, J, Thomas, V, Shams-Rony, M, Borthwick, N, Bridgeman, A, Black, A, Reilly, M, Jaoko, W, John-Stewart, G, Ambler, G, Lohman-Payne, B, Hanke, T, Flanagan, K